The antibody-drug conjugate: an enabling modality for natural product-based cancer therapeutics.

Natural product reports

Volumn 30, Issue 5, 2013, Pages 625-639

  Gerber, Hans Peter ^a   Koehn, Frank E ^b   Abraham, Robert T ^b  

^a PFIZER INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ANTINEOPLASTIC AGENT; BIOLOGICAL PRODUCT; MONOCLONAL ANTIBODY;

CHEMICAL STRUCTURE; HUMAN; NEOPLASM; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL AGENTS; HUMANS; IMMUNOCONJUGATES; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84879591299     PISSN: None     EISSN: 14604752     Source Type: None    
DOI: 10.1039/c3np20113a     Document Type: Review

References (0)